Portrait

Univ. Prof.Dr. Sebastian Schoppmann

geboren 14.7.1975 in Mainz (Deutschlabd)
E-mail: sebastian.schoppmann@meduniwien.ac.at

LEBENSLAUF (allgemein)
14.07.1975: Als erstes von drei Kindern von Univ.Doz. Dr. Axel Schoppmann, Naturwissenschaftler, und Mag. Christa Schoppmann, Gymnasiallehrerin, in Mainz, Deutschland geboren.
1980: Umzug nach San Francisco, Kalifornien.
1980-1982: Besuch der Waldorf-Schule in San Francisco.
1982-1984: Rückkehr nach Ulm, Deutschland, und Besuch der Volksschule  in Ulm.
1985: Umzug nach Klosterneuburg bei Wien und Besuch der Volksschule Weidling.
1986-1994: Besuch des BG, BRG und BORG Klosterneuburg, eusprachlicher Zweig (Französisch, Spanisch, Latein und Englisch).
20.06.1994: Reifeprüfung mit gutem Erfolg, Notendurchschnitt 1,75.
Oktober 1994: Beginn des Medizinstudiums.
1997: Beginn der Tätigkeit als wissenschaftlicher Mitarbeiter am Institut für Ultrastrukturpathologie (Univ. Prof. Kerjaschki) und dem Institut für Molekulare Pathologie (IMP) bei Univ. Prof. Christofori.
12.10.2000: Verleihung des Akademischen Grades „Doktor der  gesamten Heilkunde“ mit Ablieferung der wissenschaftlichen Arbeit (Dissertation): “Lymphatic Microvessels in Invasive Breast Tumors – a Prognostic Factor?”
1.11.2000: Beginn mit der Facharztausbildung für Chirurgie
1.11.2000- 31.3.2001:  Wissenschaftlicher Mitarbeiter im Bereich des FWF- SFB-Fonds des Instituts f. Gefäßbiol. u. Thromboseforschung (Prof. Binder).
1.04.2001-31.06.2001: Vetragsassistent am Klinischen Institut für Klinische Pathologie der Universität Wien (Univ.Prof Kerjaschki)
Seit 1.07.2001: Universitätsassistent am Klinischen Institut für Klinische Pathologie der Universität Wien (Gynäkopathologie)
Seit 1.01.2002: Gegenfach auf der Universitätsklinik für Chirurgie
Seit 1.4.2002 Universitätsassistent auf der Universitätklinik für Chirurgie (Univ.Prof Jakesz)
5.12.2006 Verleihung der Venia docendi im Fach „Chirurgie“ der Medizinischen Universität Wien.

LEBENSLAUF (wissenschaftlich):

1997 Beginn der wissenschaftlichen Tätigkeit am Institut für Ultrastrukturpathologie, Institut für klinische Pathologie (Univ.Prof.D.Kerjaschki, FWF-SFB-Fond). Erlernen proteinchemischer, molekularbiologischer sowie zellkuturtechnischer Methodik. Beginn der Dissertation (Univ.Prof.S.Geleff, Univ.Prof.G.Krupitza).

1999-2000 Ausbildung und Mitarbeit am IMP-Wien (Prof.G.Christofori)

12.10.2000 Promotion mit absolvierter Dissertation mit dem Leitthema „Lymphatic Microvessels in Invasive Breast Tumor A Prognostic Factor?“

14.10.2000 Beginn der Tätigkeit mit geteilter Stelle als Forschungs-/Aussbildungsassisten am Institut für klinische Pathologie. Projektneudefinierung Lymphangiogenese und Metastasierungsmechanismen.

2001 Assistenzart am Institut für klinische Pathologie, Wechsel auf die Universitätsklinik für Chirurgie (Univ.Prof.F.Mühlbacher), Abteilung für Allgemeinchirurgie (Univ.Prof.R.Jakesz). Das Thema Lymphangiogenese und lymphovasckuläre Metastasierung bleibt wissenschaftliches Hauptinteresse und die Umsetzung der grundlagenwissenschaftlichen Methodik in die Klinik.

2006 Arbeitsgruppenleiter „Translational Research – Angiogenese“ des chirurgischen Forschungslabors.

Wissenschaftliche PUBLIKATIONEN:

2000

  1. Schoppmann, S.F., Lymphatic Microvessels in Invasive Breast Cancer, in Department for Pathology, Department of Surgery, 2000, Medical University of Vienna: Vienna. (Thesis)

2001

  1. Kriehuber, E., S. Breiteneder-Geleff, M. Groeger, A. Soleiman, S. Schoppmann, G. Stingl, D. Kerjaschki, and D. Maurer,  Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. Journal of Investigative Dermatology, 2001. 117(6): p. 1680-1680.
  2. Kriehuber, E., S. Breiteneder-Geleff, M. Groeger, A. Soleiman, S.F. Schoppmann, G.Stingl, D. Kerjaschki, and D. Maurer,  Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. The Journal of experimental medicine, 2001. 194(6): p. 797-808.
  3. Schindl, M., G. Oberhuber, A. Obermair, S.F. Schoppmann, B. Karner, and P. Birner,  Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer research, 2001. 61(15): p. 5703-6.
  4. Schoppmann, S.F., P. Birner, P. Studer, and S. Breiteneder-Geleff,  Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer research, 2001. 21(4A): p. 2351-5.
  5. Schoppmann, S.F., M. Schindl, S. Breiteneder-Geleff, A. Soleima, G. Breitenecker, B. Karner, and P. Birner,  Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer. Anticancer research, 2001. 21(5): p. 3419-23.

2002

  1. Schindl, M., S.F. Schoppmann, H. Samonigg, H. Hausmaninger, W. Kwasny, M. Gnant, R. Jakesz, E. Kubista, P. Birner, and G. Oberhuber,  Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002. 8(6): p. 1831-7.
  2. Schoppmann, S.F., P. Birner, J. Stockl, R. Kalt, R. Ullrich, C. Caucig, E. Kriehuber, K. Nagy, K. Alitalo, and D. Kerjaschki,  Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. The American journal of pathology, 2002. 161(3): p. 947-56.
  3. Schoppmann, S.F., R. Horvat, and P. Birner,  Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review). Oncology reports, 2002. 9(3): p. 455-60.
  4. Schoppmann, S.F., R. Horvat, and P. Birner,  Lymphatic vessels and lymphangiogenesis in female cancer: Mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review). Oncology reports, 2002. 9(3): p. 455-460.
  5. Schoppmann, S.F., M. Schindl, and P. Birner, in gynecological cancer“ In: R.M. Mohan (Ed., in Research Advances in Cancer, R.M. Mohan, Editor 2002: Kerala. p. 17-21.

2003

  1. Geleff, S., S.F. Schoppmann, and G. Oberhuber,  Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease. Virchows Archiv, 2003. 442(3): p. 231-237.
  2. Schindl, M., S.F. Schoppmann, T. Strobel, H. Heinzl, C. Leisser, R. Horvat, and P. Birner,  Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003. 9(2): p. 779-85.
  3. Schoppmann, S.F., M. Schindl, G. Bayer, K. Aumayr, J. Dienes, R. Horvat, M. Rudas, M. Gnant, R. Jakesz, and P. Birner,  Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. International journal of cancer. Journal international du cancer, 2003. 104(6): p. 677-82.

2004

  1. Schoppmann, S.F., G. Bayer, K. Aumayr, S. Taucher, S. Geleff, M. Rudas, E. Kubista, H. Hausmaninger, H. Samonigg, M. Gnant, R. Jakesz, and R. Horvat,  Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Annals of surgery, 2004. 240(2): p. 306-12.
  2. Schoppmann, S.F., A. Soleiman, R. Kalt, Y. Okubo, C. Benisch, U. Nagavarapu, G.S. Herron, and S. Geleff,  Telomerase-immortalized lymphatic and blood vessel endothelial cells are functionally stable and retain their lineage specificity. Microcirculation, 2004. 11(3): p. 261-9.
  3. Valencak, J., E. Heere-Ress, T. Kopp, S.F. Schoppmann, H. Kittler, and H. Pehamberger,  Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. European journal of cancer, 2004. 40(3): p. 358-64.

2005

  1. Schoppmann, S.F.,  Lymphangiogenesis, inflammation and metastasis. Anticancer research, 2005. 25(6C): p. 4503-11.

2006

  1. Bachleitner-Hofmann, T., M. Strohschneider, P. Krieger, M. Sachet, P. Dubsky, H. Hayden, S.F. Schoppmann, R. Pfragner, M. Gnant, J. Friedl, and A. Stift,  Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma. The Journal of clinical endocrinology and metabolism, 2006. 91(11): p. 4571-7.
  2. S.F. Schoppmann,  Fenzl, A., , S. Geleff, P. Birner, F. Wrba, B. Herberger, B. Teleky, F. Herbst, I. Kuehrer, R. Jakesz, and F. Laengle,  Vascular endothelial growth factor-C expression and lymphangiogenesis in colorectal cancer. European Surgery-Acta Chirurgica Austriaca, 2006. 38: p. 149-154.
  3. Schoppmann, S., A. Fenzl, D. Tamandl, M. Bodingbauer, M. Schindl, H. Puhalla, B. Grunberger, B. Teleky, T. Grunberger, and F. Langle,  Impact of lymphangiogenesis in colorectal liver metastases. Annals of Oncology, 2006. 17: p. 33-33.
  4. Schoppmann, S.F., A. Fenzl, K. Nagy, S. Unger, G. Bayer, S. Geleff, M. Gnant, R. Horvat, R. Jakesz, and P. Birner,  VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery, 2006. 139(6): p. 839-46.
  5. Schoppmann, S.F., A. Fenzl, M. Schindl, T. Bachleitner-Hofmann, K. Nagy, M. Gnant, R. Horvat, R. Jakesz, and P. Birner,  Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast cancer research and treatment, 2006. 99(2): p. 135-41.
  6. Schoppmann, S.F. and R. Jakesz,  Early-stage breast cancer – Highlights at ASCO 2006. Breast Care, 2006. 1(4): p. 265-269.
  7. Tamandl, D., B. Gruenberger, B. Herberger, S. Schoppmann, M. Bodingbauer, E. Fleischmann, W. Schima, R. Jakesz, F. Laengle, and T. Gruenberger,  Safe surgery for colorectal cancer liver metastases using modern dissection techniques. Annals of Oncology, 2006. 17: p. 57-57.

2007

  1. Schima, W., S.F. Schoppmann, and G. Prager,  Aktuelle Bilder: Akutes Abdomen nach laparoskopischer Cholezystektomie. Journal für Gastroenterologische und Hepatologische Erkrankungen, 2007. 5(3): p. 20.
  2. Schindl, M., M. Gnant, S.F. Schoppmann, R. Horvat, and P. Birner,  Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer research, 2007. 27(2): p. 949-52.
  3. Schoppmann, S.F., D. Kandioler, and R. Horvat, Operative Verfahren beim DCIS, in Mammakarzinom: Operative Behandlungskonzepte, R. Jakesz, Editor 2007, Springer: Vienna. p. 51-61.
  4. Tamandl, D., B. Gruenberger, B. Herberger, S. Schoppmann, M. Bodingbauer, M. Schindl, H. Puhalla, E. Fleischmann, W. Schima, R. Jakesz, F. Laengle, and T. Gruenberger,  Selective resection of colorectal liver metastases. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2007. 33(2): p. 174-82.

2008

  1. Gnant, M., B. Mlineritsch, G. Luschin-Ebengreuth, F. Kainberger, H. Kassmann, J.C. Piswanger-Solkner, M. Seifert, F. Ploner, C. Menzel, P. Dubsky, F. Fitzal, V. Bjelic-Radisic, G. Steger, R. Greil, C. Marth, E. Kubista, H. Samonigg, P. Wohlmuth, M. Mittlbock, and R. Jakesz,  Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. The lancet oncology, 2008. 9(9): p. 840-9. (Collaborator)
  2. Gnant, M., S. Schoppmann, I. Kuehrer, P. Goetzinger, K. Sahora, S. Kandutsch, F. Wrba, C. Brostjan, P. Goetzinger, K. Turetschek, C. Zielinski, B. Teleky, J. Fried, A. Stift, and R. Jakesz,  Bevacizumab plus gemcitabine for the neoadjuvant treatment of locally advanced non-metastatic pancreatic cancer. Annals of Oncology, 2008. 19: p. 70-71.

    Kappel, S., C. Bichler, B. Wolf, S. Gacic, S.F. Schoppmann, Y. Devyatko, G. Prager, A. Ba-SSalamah, F. Wrba, U. Pluschnig, I. Kuhrer, M. Mittlbock, M. Hejna, J. Zacherl, D. Kandioler, and P.S. Grp,  Ein Umbruch in der chirurgischen Onkologie: Hintergrunde der aEuro cent Pancho Studie. European Surgery-Acta Chirurgica Austriaca, 2008. 40(6): p. 277-283.

  3. Mlineritsch, B., C. Tausch, C. Singer, G. Luschin-Ebengreuth, R. Jakesz, F. Ploner, M. Stierer, E. Melbinger, C. Menzel, A. Urbania, M. Fridrik, G. Steger, P. Wohlmuth, M. Gnant, and R. Greil,  Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17). Breast cancer research and treatment, 2008. 112(1): p. 203-13. (Collaborator)
  4. Schoppmann, S.F., Epidemiologie und Pathogenese von Kolorektalen Lebermetastasen, in Therapiemanagement von Lebermetastasen bei Gastrointestinalen Tumoren, T. Gruenberger, Editor 2008, Uni-Med: Bremen-London-Boston.
  5. Tamandl, D., B. Herberger, B. Gruenberger, S.F. Schoppmann, H. Puhalla, M. Schindl, W. Schima, R. Jakesz, and T. Gruenberger,  Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. Surgery, 2008. 143(5): p. 648-57.

2009

  1. Blaha, P., R. Exner, A.D. Borgo, S. Bigenzahn, P. Panhofer, O. Riedl, S. Schoppmann, T. Bachleitner-Hofmann, E. Sporn, U. Pluschnig, F. Fitzal, G. Steger, R. Jakesz, P. Dubsky, and M. Gnant,  Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio. Breast Care, 2009. 4(3): p. 155-161.
  2. Gnant, M., P. Dubsky, F. Fitzal, P. Blaha, S. Schoppmann, G. Steger, C. Marth, H. Samonigg, K. Huttner, H. Fohler, E. Ruecklinger, R. Jakesz, and R. Greil,  Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit? Clinical Breast Cancer, 2009. 9 Suppl 1: p. S18-27.
  3. Gnant, M., B. Mlineritsch, W. Schippinger, G. Luschin-Ebengreuth, S. Postlberger, C. Menzel, R. Jakesz, M. Seifert, M. Hubalek, V. Bjelic-Radisic, H. Samonigg, C. Tausch, H. Eidtmann, G. Steger, W. Kwasny, P. Dubsky, M. Fridrik, F. Fitzal, M. Stierer, E. Rucklinger, R. Greil, and C. Marth,  Endocrine therapy plus zoledronic acid in premenopausal breast cancer. The New England journal of medicine, 2009. 360(7): p. 679-91. (Collaborator)
  4. Schoppmann, S.F., E. Bareck, F. Laengle, and J. Zacherl,  Gastrointestinale Stromatumoren. Journal für Gastroenterologische und Hepatologische Erkrankungen, 2009. 7(4): p. 45-52.
  5. Schoppmann, S.F., G. Prager, F. Langer, M. Riegler, E. Fleischman, and J. Zacherl,  Fifty-five minimally invasive Esophagectomies: a single centre experience. Anticancer research, 2009. 29(7): p. 2719-25.
  6. Silberhumer, G.R., G. Gyori, C. Burghuber, C. Neumayer, M. Riegler, R. Jakesz, G. Prager, S.F. Schoppmann, and J. Zacherl,  The value of protecting the longitudinal staple line with invaginating sutures during esophageal reconstruction by gastric tube pull-up. Digestive surgery, 2009. 26(4): p. 337-41.
  7. Silberhumer, G.R., M. Hufschmid, F. Wrba, G. Gyoeri, S. Schoppmann, B. Tribl, E. Wenzl, G. Prager, F. Laengle, and J. Zacherl,  Surgery for gastrointestinal stromal tumors of the stomach. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2009. 13(7): p. 1213-9.

2010

  1. Langer, F.B., A. Bohdjalian, S. Shakeri-Leidenmuhler, S.F. Schoppmann, J. Zacherl, and G. Prager,  Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass–indications and outcome. Obesity surgery, 2010. 20(7): p. 835-40.
  2. Langer, F.B., S.F. Schoppmann, G. Prager, F.M. Riegler, and J. Zacherl,  Solving the problem of difficult stent removal due to tissue ingrowth in partially uncovered esophageal self-expanding metal stents. The Annals of thoracic surgery, 2010. 89(5): p. 1691-2.
  3. Langer, F.B., S.F. Schoppmann, G. Prager, F. Tomaselli, U. Pluschnig, M. Hejna, R. Schmid, and J. Zacherl,  Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Annals of surgical oncology, 2010. 17(2): p. 470-5.
  4. Langer, F.B., S. Shakeri-Leidenmuhler, A. Bohdjalian, S. Schoppmann, J. Zacherl, F.X. Felberbauer, G. Vila, and G. Prager,  Strategies for weight regain after sleeve gastrectomy. Surgical laparoscopy, endoscopy & percutaneous techniques, 2010. 20(3): p. 159-61.
  5. Panhofer, P., B. Izay, K. Schwameis, S. Schoppmann, G. Prager, R. Jakesz, F.M. Riegler, and J. Zacherl,  Gastrointestinal reconstructions in 1200 patients with cancer at the pharyngesophageal junction. European Surgery-Acta Chirurgica Austriaca, 2010. 42(1): p. 38-48.
  6. Schoppmann, S.F.,  Lymphangiogenese und Metastasierung. krebs:hilfe, 2010. 1/10.
  7. Schoppmann, S.F., B. Jesch, J. Friedrich, F. Wrba, A. Schultheis, U. Pluschnig, J. Maresch, J. Zacherl, M. Hejna, and P. Birner,  Expression of Her-2 in carcinomas of the esophagus. The American journal of surgical pathology, 2010. 34(12): p. 1868-73.
  8. Schoppmann, S.F., G. Prager, F.B. Langer, F.M. Riegler, B. Kabon, E. Fleischmann, and J. Zacherl,  Open versus minimally invasive esophagectomy: a single-center case controlled study. Surgical endoscopy, 2010. 24(12): p. 3044-53.
  9. Schoppmann, S.F., D. Tamandl, L. Roberts, G. Jomrich, A. Schoppmann, R. Zwrtek, P. Dubsky, M. Gnant, R. Jakesz, and P. Birner,  HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 2010. 21(5): p. 955-60.
  10. Schoppmann, S.F., K. Thomanek, M. Gnant, and R. Jakesz, The Austrian Breast and Colorectal Cancer Study Group Experience, in Kuerer’s Breast Surgical Oncology, H.M. Kuerer, Editor 2010, Mc Graw Hill Medical: Houston. p. 561-569.
  11. Starlinger, P., H.P. Moll, A. Assinger, C. Nemeth, K. Hoetzenecker, B. Gruenberger, T. Gruenberger, I. Kuehrer, S.F. Schoppmann, M. Gnant, and C. Brostjan,  Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. Journal of thrombosis and haemostasis : JTH, 2010. 8(8): p. 1809-19.

2011

  1. Ba-Ssalamah, A., W. Matzek, S. Baroud, N. Bastati, J. Zacherl, S.F. Schoppmann, M. Hejna, F. Wrba, M. Weber, C.J. Herold, and R.M. Gore,  Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results. European radiology, 2011. 21(11): p. 2326-35.
  2. Birner, P., B. Jesch, J. Friedrich, M. Riegler, J. Zacherl, M. Hejna, F. Wrba, A. Schultheis, and S.F. Schoppmann,  Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression. Annals of surgical oncology, 2011. 18(12): p. 3330-7.
  3. Birner, P., B. Jesch, J. Friedrich, A. Schultheis, and S.F. Schoppmann,  RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2011. in revision.
  4. Birner, P., B. Jesch, and S.F. Schoppmann,  Her-2 in carcinomas of the esophagus and its metastases. Virchows Archiv, 2011. 459: p. S15-S15.
  5. Birner, P. and S.F. Schoppmann,  Her-2 in gastroesophageal cancer: pathobiology, diagnostic and therapeutic implications. European Surgery-Acta Chirurgica Austriaca, 2011. 43(3): p. 162-167.
  6. Bojic, M., U. Pluschnig, J. Zacherl, C.M. Thallinger, A. Ba-Ssalamah, J. Maresch, P. Datler, S.F. Schoppmann, and M. Hejna,  Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna. Anticancer research, 2011. 31(6): p. 2379-82.
  7. Maresch, J., S.F. Schoppmann, C.M. Thallinger, C.C. Zielinski, and M. Hejna,  Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatment. Critical reviews in oncology/hematology, 2011.
  8. Pertl, L., J. Zacherl, G. Mancusi, J.N. Gachter, R. Asari, S. Schoppmann, W. Bigenzahn, and B. Schneider-Stickler,  High risk of unilateral recurrent laryngeal nerve paralysis after esophagectomy using cervical anastomosis. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies, 2011. 268(11): p. 1605-10.
  9. Schoppmann, A., D. Tamandl, B. Herberger, F. Laengle, P. Birner, S. Geleff, T. Gruenberger, and S.F. Schoppmann,  Comparison of Lymphangiogenesis between Primary Colorectal Cancer and Corresponding Liver Metastases. Anticancer research, 2011. in press.
  10. Schoppmann, S.F., E. Bareck, F. Laengle, and J. Zacherl, Gastrointestinale Stromatumoren (GIST), in ACO-ASSO Manual 3.Auflage 2011, D. Kandioler, Editor 2011: Vienna.
  11. Schoppmann, S.F., B. Jesch, J. Zacherl, F. Wrba, M. Hejna, J. Maresch, F.B. Langer, M.F. Riegler, U. Pluschnig, and P. Birner,  HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases. The British journal of surgery, 2011. 98(10): p. 1408-13.
  12. Schoppmann, S.F., E. Wenzl, and J. Zacherl, Ösophaguskarzinom, in ACO-ASSO Manual 3. Auflage 2011, D. Kandioler, Editor 2011: Vienna.
  13. Starlinger, P., L. Alidzanovic, D. Schauer, P. Brugger, S. Sommerfeldt, I. Kuehrer, S.F. Schoppmann, M. Gnant, and C. Brostjan,  Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts. Disease markers, 2011. 31(2): p. 55-65.
  14. Starlinger, P., P. Brugger, C. Reiter, D. Schauer, S. Sommerfeldt, D. Tamandl, I. Kuehrer, S.F. Schoppmann, M. Gnant, and C. Brostjan,  Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Neoplasia, 2011. 13(10): p. 980-90.
  15. Starlinger, P., P. Brugger, D. Schauer, S. Sommerfeldt, D. Tamandl, I. Kuehrer, S.F. Schoppmann, M. Gnant, and C. Brostjan,  Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. Neoplasia, 2011. 13(5): p. 419-27.
  16. Zacherl, J., S.F. Schoppmann, A. Ba-SSalamah, U. Pluschnig, M. Hejna, and F. Wrba, Magenkarzinom, in ACO-ASSO Manual 3. Auflage 2011, D. Kandioler, Editor 2011: Vienna.
  17. Fischer, S., S.F. Schoppmann, F.M. Riegler, and J. Zacherl, Radiofrequenz ablation and antireflux management for non-dysplastic Barrett’s esophagus, L. Bonavina, Editor 2012. In press
Dissertation:

S.F. Schoppmann: “Lymphatic Microvessels in Invasive Breast Tumors A Prognostic Factor?” Dissertation eingereicht Oktober 2000, 1. Begutachter: Prof. D. Kerjaschki, 2. Begutachter: Doz. G. Krupitza, Betreuerin: Prof. S. Geleff.

WISSENSCHAFTLICHE PREISE:

Billroth-Preis der Ärztekammer für Wien 2003 für die Arbeit:

S. F. Schoppmann, P. Birner, J. Stöckl, R. Kalt, R. Ullrich, E. Kriehuber, K. Nagy, K. Alitalo, Dontscho Kerjaschki: “ Tumor associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis ” Am J Pathol 2002 Sep;161(3):947-56.

Förderungspreis des Fonds der Stadt Wien für innovative interdisziplinäre Krebsforschung 2004

S. F. Schoppmann, G. Bayer, K. Aumayr, S. Taucher, S. Geleff, M. Rudas, E. Kubista, H. Hausmaninger, H. Samonigg, M. Gnant, R. Jakesz, R. Horvat; Austrian Breast and Colorectal Cancer Study Group:” Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer” Ann Surg. 2004 Aug;240(2):306-12

ACO-ASSO-Preis

S.F. Schoppmann, A. Fenzl, S. Glueck, G. Bayer, S. Geleff, M. Gnant, R. Horvat, R. Jakesz, and P. Birner: “VEGF-C-expressing tumor associated macrophages in lymph node positive breast cancer: Imapct on lymphangiogenesis and survival.” Surgery 2006 Jun;139(6):839-46.

Billroth-Preis 2007

Bachleitner-Hofmann T, Strohschneider M, Krieger P, Sachet M, Dubsky P, Hayden H, Schoppmann S.F, Pfragner R, Gnant M, Friedl J, Stift A: “Heat shock treatment of tumor lysate-pulsed DCs enhances their capacity to elicit antitumor T-cell responses against medullary thyroid carcinoma” J Clin Endocrinol Metab. 2006
Nov;91(11):4571-7.

DRITTMITTEL

Jubiläumsfond der Österreichischen Nationalbank 2006

„Vorhersage des Ansprechens auf anti-angiogenetische Tumortherapie“ Projektnummer 12072. Bewilligungsdatum 29.06.2006. Projektleiter: Dr. Sebastian Schoppmann, bew. Summe: 75 000 €

Hans-Blanca Moser Stiftung

„Lymphangiogenesis and lymphovascular invasion in liver metastasis of colorectal cancer“ (A. Fenzl)

WISSENSCHAFTLICHE PRÄSENTATIONEN (Auswahl)

S. F. Schoppmann, M. Schindl, P. Birner, M. Gnant, R. Jakesz , G. Oberhuber: “ Hypoxia inducible factor-1a beim Lymphknoten-positiven Brustkrebs “. Angenommen als Vortrag bei der 18. Jahrestagung der ÖGS 11. – 13. Oktober 2001, Gmunden. (talk)

P. Birner, M. Schindl, S. F. Schoppmann. R. Horvat: „. Evaluation of the United States Food and Drug Administration – approved scoring and test system of HER-2 protein expression in breast cancer”Angenommen als Vortrag bei der 18. Jahrestagung der ÖGS 11. – 13. Oktober 2001, Gmunden. (talk)

P. Birner, M. Schindl, S. F. Schoppmann: “The role of lymphatic vessels in cervical and ovarian cancer”. Eingeladener Vortrag beim 6th World Congress on Advances in Oncology, Oktober 2001, Kreta, Griechenland. (talk)

S. F. Schoppmann, M. Schindl, P. Birner, R. Horvat: “Inflammatory stroma reaction correlates with lymphatic microvessel density in early-stage cervical cancer” Angenommen als Vortrag bei der 86. Jahrestagung der Deutschen Gesellschaft für Pathologie, 3.-6. April 2002, Wien. (talk)

M. Schindl, S. F. Schoppmann, T. Ströbel, C. Leisser, P. Birner, R. Horvat: “Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clincial behavior of epithelial ovarian tumors ” Vortrag bei der 86. Jahrestagung der Deutschen Gesellschaft für Pathologie, 3.-6. April 2002, Wien. (talk)

P. Birner, M. Schindl, S. F. Schoppmann: The role of lymphatic vessels in cervical and ovarian cancer.International Journal of Molecular Medicine 8 (Suppl 1)/ 2001, S36. (abstract)

S. F. Schoppmann, K. Alitalo, D. Kerjaschki and Peter Birner: Tumor-associated macrophages express VEGF-C and VEGF-D and are reöated to peritumoral Lymphangiogenesis” 7th World Congress on Advances in Oncologyand5th International Symposium on Molecular Medicine October 10-12, 2002 Creta Maris Hotel, Hersonissos, Crete, Greece (poster)

S.F. Schoppmann and Silvana Geleff: “ Telomerase-immortalized lymphatic and blood vessel endothelial cells are functional stable and retain their lineage specificity”
Präsentation der Wissenschaftlichen Highlights 2003 und Wissenschaftliche Sommertagung der Gesellschaft der Ärzte in Wien

P. Birner, M. Schindl, S. F. Schoppmann: “The role of lymphatic vessels in cervical and ovarian cancer”. Eingeladener Vortrag beim 6th World Congress on Advances in Oncology, Oktober 2001, Kreta, Griechenland. (talk)

S. F. Schoppmann, M. Schindl, P. Birner, R. Horvat: “Inflammatory stroma reaction correlates with lymphatic microvessel density in early-stage cervical cancer” Angenommen als Vortrag bei der 86. Jahrestagung der Deutschen Gesellschaft für Pathologie, 3.-6. April 2002, Wien. (talk)

M. Schindl, S. F. Schoppmann, T. Ströbel, C. Leisser, P. Birner, R. Horvat: “Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clincial behavior of epithelial ovarian tumors ” Vortrag bei der 86. Jahrestagung der Deutschen Gesellschaft für Pathologie, 3.-6. April 2002, Wien. (talk)

P. Birner, M. Schindl, S. F. Schoppmann: The role of lymphatic vessels in cervical and ovarian cancer.International Journal of Molecular Medicine 8 (Suppl 1)/ 2001, S36. (abstract)

S.F. Schoppmann and Silvana Geleff: “ Telomerase-immortalized lymphatic and blood vessel endothelial cells are functional stable and retain their lineage specificity” FWF- Posterpräsentation 2003, Wien, AKH Wien

S. F. Schoppmann: “Therapieoptionen beim hepatozellulären Karzinom” Vortrag im Rahmen Life-OP Workshop, Wien 24.-25. April 2006 (talk)

S F. Schoppmann, Alexandra Fenzl, Dietmar Tamandl, Martin Bodingbauer, Martin Schindl, Beata Herrberger, Ehard Schwanzer, Harald Puhalla, Birgit Grünberger, Bela Teleky, Thomas Grünberger and Friedrich Längle:” Lymphangiogenesis and colorectal liver metasases” 7th World Congress of Gastrointestinal Cancer (Poster), 28.6-2.7.2006, Barcelona, Spanien

Tamandl D, Gruenberger B, Herberger B, S.F. Schoppmann, Bodingbauer M, Fleischmann E, Schima W, Jakesz R, Laengle F, Gruenberger T.:” Safe surgery for colorectal cancer liver metastases using modern dissection techniques” Annals of Oncology, Volume 17, 2006 Supplement 6.

S. F. Schoppmann:” Hypoxia-inducible Factor 1alpha correlates with VEGF-C and lymphangiogenesis in invasive breast cancer” 47. Österreichischer Chirurgenkongress 15.-17. Juni 2006 (talk)

S. F. Schoppmann:”The role of VEGF-C expressing macrophages in invasive breast cancer” 47. Österreichischer Chirurgenkongress 15.-17. Juni 2006 (talk)

S. F. Schoppmann:” The clinical impact of lymphangiogenesis in colorectal liver-metastases” 47. Österreichischer Chirurgenkongress 15.-17. Juni 2006 (talk)

D. Tamandl, B. Grünberger, B. Herrberger, S.F. Schoppmann, M. Bodingbauer, R. Jakesz, F. Längle, T. Grünberger” Resection od colorectal liver metastases under the aspect of modern dissection techniques” 47. Österreichischer Chirurgenkongress 15.-17. Juni 2006 (talk)

M. Bodingbauer, D. Tamandl, S. Kandutsch, C. Plank, S.F. Schoppmann, W. Schima, F. Laengle, T. Grünberger:” Effect of surgical margin status on survival after hepatic resection for colorectal metastases” 47. Österreichischer Chirurgenkongress 15.-17. Juni 2006 (talk)

S.F. Schoppmann: “Lymphangiogenesis in Barrett-Carcinoma” Talk at 1. Österreichisches Ösophagus SymposiumThema: Barrett – Ösophagus
Datum: 29. September 2006 Ort: Billroth-Haus, Frankgasse 8, A – 1090 Wien

CONSULTING EDITOR FOR:

Annals of Surgical Oncology, Journal of Leucocyte Biology, Acta Biologica Hungarica, British Journal of Cancer, British Journal of Surgery, Oncology, Deutsche Forschungsgemeinschaft (DFG), British Journal of Oncology, BMC Cancer, Cell and Molecular Life Science, World Journal of Surgical Oncology.

Consulting Editor for Journal of Leucocyte Biology

Associate Edfitor für European Journal of surgical Oncology

BETREUTE DIPLOMANTEN UND DISSERTANTEN:

SS2003 Dr. med. Julia Dienes (Dissertation)
WS2004/2005 Dr. med. Alexandra Fenzl (Dissertation)
WS2006/2007 c.m Gerd Jomrich (Diplomarbeit)
WS2006/2007 c.m Lisa Roberts (Diplomarbeit)

MITGLIEDSCHAFTEN BEI MEDIZINISCHEN GESELLSCHAFTEN:

  • Österreichischen Gesellschaft für chirurgische Onkologie (ACO-ASSO)
  • Österreichische Gesellschaft für Chirurgie
  • Österreichische Gesellschaft für Senologie
  • American Society of Clinical Oncology (ASCO)
  • Austrian Breast and Colorectal Cancer Study Group (ABCSG)
  • European Society of Medical Oncology (ESMO)

WEITERE FUNKTIONEN:

Consulent des niederösterreichischen NÖ Gesundheits- und Sozialfonds

ERNENNUNGEN:

05.12.06 Verleihung der Venia docendi für das Fach Chirurgie

01.03.2007 Verleihung des Titel Außerordendlicher Universitätsprofessor